Viewing Study NCT00481169


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-06 @ 12:57 PM
Study NCT ID: NCT00481169
Status: COMPLETED
Last Update Posted: 2009-08-21
First Post: 2007-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-07
Start Date Type: None
Primary Completion Date: 2004-07
Primary Completion Date Type: ACTUAL
Completion Date: 2004-09
Completion Date Type: ACTUAL
First Submit Date: 2007-05-30
First Submit QC Date: None
Study First Post Date: 2007-06-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-08-20
Last Update Post Date: 2009-08-21
Last Update Post Date Type: ESTIMATED